CMS Clarifies CLIA Certification Requirements for Remote Cytology

CMS Clarifies CLIA Certification Requirements for Remote Cytology

The Centers for Medicare & Medicaid Services (CMS) recently clarified Clinical Laboratory Improvement Act (CLIA) certification requirements for remote cytology.

The College of American Pathologists (CAP) requested clarification because of recent federal policy updates, including updates to requirements related to CLIA certification for laboratories. CMS officials explained that remote Rapid Adequacy Assessments (also known as rapid on-site evaluation or ROSE) require a separate CLIA certificate for an off-site location where a review is performed, including virtual slide review. CMS also clarified that adequacy assessment does not count as a separate examination for workload limit purposes.

Source:

https://www.cap.org/advocacy/latest-news-and-practice-data/march-31-2026#story2

Congressional Opposition to WISeR Model Demands Performance Data From CMS

Congressional Opposition to WISeR Model Demands Performance Data From CMS

A congressional coalition sent a letter on June 22 to Centers for Medicare and Medicaid Services (CMS) Administrator Mehmet Oz, M.D., expressing...

Read More
Final Month of PAMA Reporting: Is Your Lab Ready?

Final Month of PAMA Reporting: Is Your Lab Ready?

July marks the final month of the 2026 PAMA reporting period. Laboratories that meet the definition of an applicable laboratory, which most do, have...

Read More
Humana Claims Payment Policies

Humana Claims Payment Policies

Effective July 1, 2026, Humana will charge a $5.00 administrative fee for Medicare Advantage paper claim submissions.

Read More